Advisers to the agency overwhelmingly agreed that a new treatment would help to prevent a potentially lethal respiratory illness in very young children.
Tag: Sanofi SA
RSV Vaccine Approved for Older Adults
The shots would be the first vaccines available against a respiratory virus that kills thousands and leads to many more hospitalizations each year.
Vacunar a todo el mundo no es fácil. Esta es la razón
Una gran parte de la desigualdad en el acceso a las vacunas se explica por el acaparamiento de las grandes potencias. Pero fabricarlas también es un desafío sin precedentes.
Covid-19: Why It’s Hard to Vaccinate the World
Big-power muscle flexing helps explain much of the world’s vaccine inequities, but there’s another reason behind insufficient doses: The challenge of making them is unprecedented.
Where Europe Went Wrong in Its Vaccine Rollout, and Why
While Washington went into business with the drug companies, Europe was more fiscally conservative and trusted the free market.
Moderna Vaccine Is Highly Protective and Prevents Severe Covid, Data Show
The positive review most likely ensures that the Food and Drug Administration will grant emergency authorization to a second coronavirus vaccine this week for millions of Americans.
Sanofi Accelerates Its Timeline for Coronavirus Vaccine Development
The French drugmaker is testing two types of vaccines in a bid to catch up to competitors.
To Drive Down Insulin Prices, W.H.O. Will Certify Generic Versions
About 80 million people with diabetes around the world need the hormone, and half of them can’t afford it. Creating competition could help, the agency said.
A Simple Regimen Can Prevent TB. Why Aren’t More People on It?
Two antibiotics, taken for a month, can stop a leading killer. But “when it’s for TB, people just sort of shrug.”
Drug Companies Are Focusing on the Poor After Decades of Ignoring Them
The pharmaceutical industry once sued to keep AIDS drugs from dying Africans. Now companies boast of their efforts to get medicines to the developing world.